Keio Prize In Medicine For Development Of Molecular Target Lung Cancer Drug
This article was originally published in PharmAsia News
Keio University announced September 10 it has awarded this year’s Keio Medical Science Prize for outstanding achievement in the field of life science and medicine to Jichi Medical University’s Hiroyuki Mano and U.S. National Cancer Institute Chief of Surgery Steven Rosenburg.
You may also be interested in...
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Sandoz has appointed a new leader for its Japanese business following the acquisition of Aspen’s local operations, while Stada has brought in a former Sandoz and Pfizer executive to lead its Ciclum Farma unit in Portugal. Meanwhile, Julphar has a new CEO.
The impact of the coronavirus pandemic on investors’ portfolios was immediately apparent at the end of the first quarter of 2020. Equity market sell-offs are reflections of investors’ concern for future financial performance which, if material, may have to be announced early.